Oxerutins

DB15826InvestigationalSmall molecule

Oxerutins is a flavonoid antioxidant indicated in the treatment of venous insufficiency and capillary fragility. A medication used to treat foot and ankle swelling caused by poor blood flow.

Also known as: O-(ß-hydroxyethyl) rutosides · Oxerutins, unspecified

Resolves to

Clinical / RWD

RxNorm67187

What you can answer from here — as of March 06, 2025

2Clinical trialsPhase, status and sponsor resolved per trial

2Structured indicationsCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

19Marketed productsAcross 3 countries and 5 labellers

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Oxerutins, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account